US 7078209
CAK inhibitors and uses thereof
granted A61KA61K31/437A61P
Quick answer
US patent 7078209 (CAK inhibitors and uses thereof) held by Vertex Pharmaceuticals Incorporated expires Mon Jul 13 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Jul 18 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 13 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K31/437, A61P, A61P1/14, A61P31/10